Olesova Dominika, Galba Jaroslav, Piestansky Juraj, Celusakova Hana, Repiska Gabriela, Babinska Katarina, Ostatnikova Daniela, Katina Stanislav, Kovac Andrej
Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 84510 Bratislava, Slovakia.
Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32 Bratislava, Slovakia.
Metabolites. 2020 Nov 2;10(11):443. doi: 10.3390/metabo10110443.
Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child's perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients' group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers.
自闭症谱系障碍是一种异质性神经发育疾病。目前,尚无该疾病的生物标志物。诊断通过观察、标准化行为量表以及与家长访谈来进行。在实际中,诊断往往延迟至平均四岁甚至更晚,这对儿童的前景产生不利影响。非常需要一种能够在早期阶段检测该疾病的实验室方法,因为这有助于患者在更小的年龄,甚至在临床诊断之前就开始治疗。最近的证据表明,代谢组学标志物应被视为诊断标志物,也可用于自闭症谱系不同亚组的进一步区分和特征描述。在本研究中,我们开发了一种超高效液相色谱 - 串联三重四极杆质谱法,用于同时测定人尿液中的六种代谢物。根据先前的代谢组学研究,这些代谢物,即甲基胍、N - 乙酰精氨酸、肌苷、吲哚 - 3 - 乙酸、硫酸吲哚酚和黄尿酸被选为潜在的生物标志物。分析通过反相液相色谱梯度洗脱进行。代谢物在Phenomenex Luna Omega Polar C18(100×1.0 mm,1.6 µm)柱上以0.15 mL/min的流速进行分离,流动相为乙腈/水0.1%甲酸水溶液。对一组自闭症谱系障碍儿童和年龄匹配的对照组进行了分析。在学龄儿童中,我们检测到与精氨酸和嘌呤代谢相关的氧化应激标志物水平存在紊乱,即甲基胍和N - 乙酰精氨酸。此外,在患者组中发现肠道细菌代谢产物,即硫酸吲哚酚和吲哚 - 3 - 乙酸升高。我们可以得出结论,这种新开发的方法快速、灵敏、可靠,非常适合对所提出的标志物进行定量分析。